http://purl.org/np/RA__616KtA... RA__616KtA

links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion

http://www.w3.org/1999/02/22-rdf-syntax-ns#type type

http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement Statement

Leoni Bücken

2021-07-03T09:41:09.959Z

http://purl.org/np/RA__616KtA... RA__616KtA

links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion

http://www.w3.org/2000/01/rdf-schema#label label

fanapt r see clinical studies 14 when deciding among the alternative treatments available for this condition the prescriber should consider the finding that fanapt see warnings and precaution s 5 2 patients must be titrated to an effective dose of fanapt s ee dosage and administration 2 1 and clinical studies 14 the effectiveness of fanapt in long term use that is for more than 6 weeks has not been systematically evaluated in controlled trials therefore the physician who elects to use fanapt for extended periods should periodically re evaluate the long term usefulness of the drug for the individual patient s ee dosage and administration 2 3 fanapt is an atypical antipsychotic agent indicated for the treatment of schizophrenia in adults 1 14

Leoni Bücken

2021-07-03T09:41:09.959Z

http://purl.org/np/RA__616KtA... RA__616KtA

links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion

http://www.w3.org/1999/02/22-rdf-syntax-ns#object object

http://purl.obolibrary.org/obo/DOID_5419 DOID_5419

Leoni Bücken

2021-07-03T09:41:09.959Z

http://purl.org/np/RA__616KtA... RA__616KtA

links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion

http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate predicate

https://w3id.org/biolink/vocab/treats treats

Leoni Bücken

2021-07-03T09:41:09.959Z

http://purl.org/np/RA__616KtA... RA__616KtA

links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion

http://www.w3.org/1999/02/22-rdf-syntax-ns#subject subject

https://identifiers.org/drugbank:DB04946 drugbank:DB04946

Leoni Bücken

2021-07-03T09:41:09.959Z

http://purl.org/np/RA__616KtA... RA__616KtA

links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion

https://w3id.org/biolink/vocab/association_type association_type

https://w3id.org/biolink/vocab...OrPhenotypicFeatureAssociation ChemicalToDiseaseOrPhenotypicFeatureAssociation

Leoni Bücken

2021-07-03T09:41:09.959Z

http://purl.org/np/RA__616KtA... RA__616KtA

links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion

https://w3id.org/biolink/vocab/provided_by provided_by

https://w3id.org/um/NeuroDKG NeuroDKG

Leoni Bücken

2021-07-03T09:41:09.959Z

http://purl.org/np/RA__616KtA... RA__616KtA

links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion

https://w3id.org/biolink/vocab/relation relation

https://schema.org/TreatmentIndication TreatmentIndication

Leoni Bücken

2021-07-03T09:41:09.959Z